TriSalus Life Sciences Announces Board and Officer Changes
Ticker: TLSIW · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1826667
| Field | Detail |
|---|---|
| Company | Trisalus Life Sciences, Inc. (TLSIW) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50, $450,000, $550,000, $5.11 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, officer-appointment
TL;DR
Board shakeup at TriSalus - new directors in, some execs out. Watch for strategy shifts.
AI Summary
TriSalus Life Sciences, Inc. announced on August 25, 2025, changes in its board of directors and officer appointments. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. Specific names and dollar amounts related to these changes are not detailed in this summary section of the 8-K.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, operational focus, or financial direction, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and officer appointments can indicate internal restructuring or strategic pivots, which carry inherent risks.
Key Numbers
- 001-39813 — SEC File Number (Identifies the company's filing with the SEC.)
- 853009869 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- TriSalus Life Sciences, Inc. (company) — Registrant
- MedTech Acquisition Corp (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- August 25, 2025 (date) — Date of earliest event reported
FAQ
What specific roles have been affected by the departures and appointments?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', suggesting shifts in key leadership positions.
When did the reported changes take effect?
The date of the earliest event reported is August 25, 2025.
What was TriSalus Life Sciences, Inc. formerly known as?
The company was formerly known as MedTech Acquisition Corp, with a name change date of September 30, 2020.
Where is TriSalus Life Sciences, Inc. headquartered?
The company's principal executive office is located at 6272 W 91st Ave, Westminster, Colorado 80031.
What is the SIC code for TriSalus Life Sciences, Inc.?
The Standard Industrial Classification code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-08-29 16:15:06
Key Financial Figures
- $0.0001 — ange on which registered Common stock, $0.0001 par value TLSI Nasdaq Global Market
- $11.50 — 's common stock at an exercise price of $11.50 per share TLSIW Nasdaq Global Market
- $450,000 — 's Chief Financial Officer, from the he $450,000 annual base salary indicated in his Exe
- $550,000 — loyment Agreement dated May 27, 2025 to $550,000, effective immediately. In addition, o
- $5.11 — n stock to Mr. Patience, exercisable at $5.11 per share. The options vest upon the Co
- $75 million — upon the Company achieving or exceeding $75 million of revenue over any twelve (12) consecu
Filing Documents
- tlsi-20250825.htm (8-K) — 25KB
- 0001826667-25-000129.txt ( ) — 183KB
- tlsi-20250825.xsd (EX-101.SCH) — 2KB
- tlsi-20250825_def.xml (EX-101.DEF) — 16KB
- tlsi-20250825_lab.xml (EX-101.LAB) — 28KB
- tlsi-20250825_pre.xml (EX-101.PRE) — 17KB
- tlsi-20250825_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 29, 2025 TriSalus Life Sciences, Inc. By: /s/ Mary Szela Name: Mary Szela Title: Chief Executive Officer